Bing Liao

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0003-4613-7929

发表论文 68 篇 · 总被引 2244 次 · h-index 21

代表论文

• A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease (2023 · Journal of Hepatology · 被引 126)
• circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis (2021 · Molecular Cancer · 被引 68)
• Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study (2023 · The Lancet Digital Health · 被引 48)
• Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis (2025 · JAMA Network Open · 被引 23)
• A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma (2024 · Nature Communications · 被引 21)
• Pridopidine in Amyotrophic Lateral Sclerosis (2025 · JAMA · 被引 20)